Literature DB >> 7519801

Plasma FK506 levels in patients with histopathologically documented renal allograft rejection.

E Erden, V Warty, M Magnone, R Shapiro, J Demetris, P Randhawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7519801

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.

Authors:  P S Randhawa; A C Tsamandas; M Magnone; M Jordan; R Shapiro; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1996-03       Impact factor: 6.394

Review 3.  Interpreting tacrolimus concentrations during pregnancy and postpartum.

Authors:  Mary F Hebert; Songmao Zheng; Karen Hays; Danny D Shen; Connie L Davis; Jason G Umans; Menachem Miodovnik; Kenneth E Thummel; Thomas R Easterling
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

4.  Factors affecting variability in distribution of tacrolimus in liver transplant recipients.

Authors:  H Zahir; G McCaughan; M Gleeson; R A Nand; A J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

5.  Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major.

Authors:  Chengxin Li; Jiejiu Lu; Siru Zhou; Yinyi Wei; Chunle Lv; Taotao Liu; Yun Wu; Dongni Wu; Jianying Qi; Rongda Cai
Journal:  Pharmgenomics Pers Med       Date:  2021-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.